Literature DB >> 6695172

A new type D retrovirus isolated from macaques with an immunodeficiency syndrome.

M D Daniel, N W King, N L Letvin, R D Hunt, P K Sehgal, R C Desrosiers.   

Abstract

Macaque monkeys with the recently described acquired immunodeficiency syndrome show a marked defect in T-lymphocyte function and die with opportunistic infections and lymphoproliferative abnormalities. In the study described here a new type D retrovirus was isolated from two Macaca cyclopis with this syndrome. This virus is related to, but distinct from, Mason-Pfizer monkey virus, a type D retrovirus previously isolated from a mammary tumor of a rhesus monkey (Macaca mulatta).

Entities:  

Mesh:

Year:  1984        PMID: 6695172     DOI: 10.1126/science.6695172

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  57 in total

1.  Virus load and sequence variation in simian retrovirus type 2 infection.

Authors:  L L Rosenblum; R A Weiss; M O McClure
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus.

Authors:  M Marin; C S Tailor; A Nouri; D Kabat
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Variable sensitivity to substitutions in the N-terminal heptad repeat of Mason-Pfizer monkey virus transmembrane protein.

Authors:  Chisu Song; Eric Hunter
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

4.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

Review 5.  Nonhuman primate models in the genomic era: a paradigm shift.

Authors:  Eric J Vallender; Gregory M Miller
Journal:  ILAR J       Date:  2013

6.  Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.

Authors:  S L Hu; J M Zarling; J Chinn; B M Travis; P A Moran; J Sias; L Kuller; W R Morton; G Heidecker; R E Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2.

Authors:  C C Tsai; K E Follis; M Yarnall; G A Blakley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Persistence and dissemination of simian retrovirus type 2 DNA in relation to viremia, seroresponse, and experimental transmissibility in Macaca fascicularis.

Authors:  Roseanne C Wilkinson; Claire K Murrell; Rebecca Guy; Gail Davis; Joanna M Hall; David C North; Nicola J Rose; Neil Almond
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Subcutaneous fibromatosis associated with an acquired immune deficiency syndrome in pig-tailed macaques.

Authors:  C C Tsai; T F Warner; H Uno; W E Giddens; H D Ochs
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

10.  Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer monkey virus versus activity of human cell line derived virus PMFV.

Authors:  J Denner; L Indzhiia; V Wunderlich; G Sydow; D Bierwolf; B A Lapin
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.